Healthcare information provider Wolters Kluwer Health (WK Health), US, has announced the publication of Cardiovascular Endocrinology, a new online, peer-reviewed journal committed to fostering effective collaboration between cardiologists and endocrinologists in addressing diabetes, hypertension, dyslipidemia, and related diseases and conditions. Lippincott Williams & Wilkins (LWW), a part of Wolters Kluwer Health, is the publisher of record for the journal.
Highlights of the inaugural issue include original research on a potential role for natriuretic peptide therapy in human cardiac ischemia and a review article on the role of melatonin in hypertension. In addition, subscribers have an opportunity to earn CME credit - provided by the Lippincott CME Institute - through LWW’s XtraCredit mobile application.
The editorial board encourages prospective authors to submit original manuscripts for publication in Cardiovascular Endocrinology. The online quarterly journal is available to individual subscribers via LWW's online journal platform and institutional access is provided through OvidSP, a medical research platform from Ovid, also a part of Wolters Kluwer Health.
Cardiovascular Endocrinology publishes peer-reviewed research in vascular disease, endocrinology, and metabolism. Particular emphasis is placed on studies that illuminate the interaction between these disciplines. The journal serves as a single resource for the cardiology, endocrinology and metabolism research, and clinical communities. High quality state-of-the-art reviews, invited editorials, and expert commentaries place original articles in context at the interface of basic and clinical research.
